Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark - PubMed (original) (raw)
Comparative Study
Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark
A G Mølbak et al. Diabet Med. 1994 Aug-Sep.
Erratum in
- Diabet Med 1995 Apr;12(4):288
Abstract
The incidence of IDDM in the age group over 30 years was estimated in a historical prospective study, using clinical and biochemical measurements at onset as criteria for classification. The study population, nearly one million, represents 20% of the Danish population. The degree of ascertainment was > 99%. One thousand two hundred and forty patients were treated with insulin during the study period (1973-77). Based on the clinical and biochemical variables, the patients were classified into three groups: insulin-dependent diabetes mellitus (IDDM) accounted for 16.2%, insulin-treated diabetes mellitus for 54.1% and short-term treated diabetes mellitus for 29.6% of the total insulin-treated group. The incidence of IDDM in the age group over 30 years at onset was 8.2 100,000(-1) year-1. The cumulative incidence rate (0-90 years) was 1.5-1.6 per cent. The present study indicates that IDDM may develop at any age. Thus the life-time risk of developing IDDM is higher than hitherto expected.
Similar articles
- Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (DISS) Group.
Kockum I, Lernmark A, Dahlquist G, Falorni A, Hagopian WA, Landin-Olsson M, Li LC, Luthman H, Palmer JP, Sanjeevi CB, Sundkvist G, Ostman IJ. Kockum I, et al. Horm Metab Res. 1996 Jul;28(7):344-7. doi: 10.1055/s-2007-979811. Horm Metab Res. 1996. PMID: 8858382 - Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry.
Vandewalle CL, Coeckelberghs MI, De Leeuw IH, Du Caju MV, Schuit FC, Pipeleers DG, Gorus FK. Vandewalle CL, et al. Diabetes Care. 1997 Oct;20(10):1556-61. doi: 10.2337/diacare.20.10.1556. Diabetes Care. 1997. PMID: 9314635 - Anti-GAD65 autoantibody in Taiwanese patients with insulin-dependent diabetes mellitus: effect of HLA on anti-GAD65 positivity and clinical characteristics.
Chuang LM, Lin CY, Wu HP, Tsai WY, Tai TY, Lin BJ. Chuang LM, et al. Clin Endocrinol (Oxf). 1997 Oct;47(4):455-61. doi: 10.1046/j.1365-2265.1997.2851090.x. Clin Endocrinol (Oxf). 1997. PMID: 9404444 - Heterogeneity of type 1 diabetes at onset in children: results from the French Incidence Study.
Levy-Marchal C, Czernichow P. Levy-Marchal C, et al. Diabete Metab. 1993 May-Jun;19(3):296-303. Diabete Metab. 1993. PMID: 8405620 - The interface between epidemiology and molecular biology in the search for the causes of insulin-dependent diabetes mellitus.
Drash AL, Lipton RB, Dorman JS, Becker DJ, LaPorte RE, Orchard TJ, Riley WJ, Trucco M, Kuller LH. Drash AL, et al. Ann Med. 1991 Oct;23(4):463-71. doi: 10.3109/07853899109148090. Ann Med. 1991. PMID: 1930943 Review.
Cited by
- Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020.
Rodríguez Escobedo R, Lambert C, Morales Sánchez P, Delgado Álvarez E, Menéndez Torre E. Rodríguez Escobedo R, et al. Diabetol Metab Syndr. 2023 May 3;15(1):90. doi: 10.1186/s13098-023-01069-y. Diabetol Metab Syndr. 2023. PMID: 37138364 Free PMC article. - The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions.
Harding JL, Wander PL, Zhang X, Li X, Karuranga S, Chen H, Sun H, Xie Y, Oram RA, Magliano DJ, Zhou Z, Jenkins AJ, Ma RCW. Harding JL, et al. Diabetes Care. 2022 Apr 1;45(4):994-1006. doi: 10.2337/dc21-1752. Diabetes Care. 2022. PMID: 35349653 Free PMC article. Review. - A composite immune signature parallels disease progression across T1D subjects.
Speake C, Skinner SO, Berel D, Whalen E, Dufort MJ, Young WC, Odegard JM, Pesenacker AM, Gorus FK, James EA, Levings MK, Linsley PS, Akirav EM, Pugliese A, Hessner MJ, Nepom GT, Gottardo R, Long SA. Speake C, et al. JCI Insight. 2019 Dec 5;4(23):e126917. doi: 10.1172/jci.insight.126917. JCI Insight. 2019. PMID: 31671072 Free PMC article. - Epidemiology of Diabetes and Hearing Loss.
Baiduc RR, Helzner EP. Baiduc RR, et al. Semin Hear. 2019 Nov;40(4):281-291. doi: 10.1055/s-0039-1697643. Epub 2019 Oct 9. Semin Hear. 2019. PMID: 31602091 Free PMC article. Review. - Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune Disease.
Hughes JW, Bao YK, Salam M, Joshi P, Kilpatrick CR, Juneja K, Nieves D, Bouhairie V, Jordan OJ, Blustein EC, Tobin GS, McGill JB. Hughes JW, et al. Diabetes Care. 2019 Jan;42(1):32-38. doi: 10.2337/dc18-1157. Epub 2018 Oct 25. Diabetes Care. 2019. PMID: 30361208 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical